Skip to main content
Fig. 2 | Inflammation and Regeneration

Fig. 2

From: Stem cell-based drug delivery strategy for skin regeneration and wound healing: potential clinical applications

Fig. 2

Characterization of bioengineered stem cell membrane nanocarriers (BSMNCs) and revascularization of ischemic limb and reduction of limb loss of BSMNCs and stem cell membrane nanocarriers (SMNCs) in a murine hindlimb ischemia model [45]. A Schematic showing the preparation of BSMNCs. B Representative laser Doppler perfusion imaging of hindlimb ischemia treated with SMNCs or VEGF-BSMNCs. C Physiological status of ischemic hind limb before and 28 days after injection. Reproduced from Bose et al. with permission from Elsevier Ltd., Copyright 2018

Back to article page

Inflammation and Regeneration

ISSN: 1880-8190

Contact us